Literature DB >> 10417279

Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease.

C Mimault1, G Giraud, V Courtois, F Cailloux, J Y Boire, B Dastugue, O Boespflug-Tanguy.   

Abstract

Pelizaeus-Merzbacher Disease (PMD) is an X-linked developmental defect of myelination affecting the central nervous system and segregating with the proteolipoprotein (PLP) locus. Investigating 82 strictly selected sporadic cases of PMD, we found PLP mutations in 77%; complete PLP-gene duplications were the most frequent abnormality (62%), whereas point mutations in coding or splice-site regions of the gene were involved less frequently (38%). We analyzed the maternal status of 56 cases to determine the origin of both types of PLP mutation, since this is relevant to genetic counseling. In the 22 point mutations, 68% of mothers were heterozygous for the mutation, a value identical to the two-thirds of carrier mothers that would be expected if there were an equal mutation rate in male and female germ cells. In sharp contrast, among the 34 duplicated cases, 91% of mothers were carriers, a value significantly (chi2=9. 20, P<.01) in favor of a male bias, with an estimation of the male/female mutation frequency (k) of 9.3. Moreover, we observed the occurrence of de novo mutations between parental and grandparental generations in 17 three-generation families, which allowed a direct estimation of the k value (k=11). Again, a significant male mutation imbalance was observed only for the duplications. The mechanism responsible for this strong male bias in the duplications may involve an unequal sister chromatid exchange, since two deletion events, responsible for mild clinical manifestations, have been reported in PLP-related diseases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10417279      PMCID: PMC1377935          DOI: 10.1086/302483

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  37 in total

1.  Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients.

Authors:  C Lázaro; A Gaona; P Ainsworth; R Tenconi; D Vidaud; H Kruyer; E Ars; V Volpini; X Estivill
Journal:  Hum Genet       Date:  1996-12       Impact factor: 4.132

2.  MSP RFLP for X-linked proteolipid protein gene (PLP) identified with either rat or human PLP cDNA clone.

Authors:  J S Wu; J R Riordan; H F Willard; R Milner; K K Kidd
Journal:  Nucleic Acids Res       Date:  1987-02-25       Impact factor: 16.971

3.  7q11.23 deletions in Williams syndrome arise as a consequence of unequal meiotic crossover.

Authors:  Z Urbán; C Helms; G Fekete; K Csiszár; D Bonnet; A Munnich; H Donis-Keller; C D Boyd
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

4.  Pelizaeus-Merzbacher disease: clinical and nosological study.

Authors:  J Boulloche; J Aicardi
Journal:  J Child Neurol       Date:  1986-07       Impact factor: 1.987

5.  Fine mapping of de novo CMT1A and HNPP rearrangements within CMT1A-REPs evidences two distinct sex-dependent mechanisms and candidate sequences involved in recombination.

Authors:  J Lopes; N Ravisé; A Vandenberghe; F Palau; V Ionasescu; M Mayer; N Lévy; N Wood; N Tachi; P Bouche; P Latour; M Ruberg; A Brice; E LeGuern
Journal:  Hum Mol Genet       Date:  1998-01       Impact factor: 6.150

6.  Molecular definition of the chromosome 7 deletion in Williams syndrome and parent-of-origin effects on growth.

Authors:  L A Pérez Jurado; R Peoples; P Kaplan; B C Hamel; U Francke
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

7.  A partial deletion of the muscular dystrophy gene transmitted twice by an unaffected male.

Authors:  B T Darras; U Francke
Journal:  Nature       Date:  1987 Oct 8-14       Impact factor: 49.962

8.  The gene encoding for the major brain proteolipid (PLP) maps on the q-22 band of the human X chromosome.

Authors:  M G Mattei; P M Alliel; A Dautigny; E Passage; D Pham-Dinh; J F Mattei; P Jollès
Journal:  Hum Genet       Date:  1986-04       Impact factor: 4.132

9.  Pelizaeus-Merzbacher disease: identification of Xq22 proteolipid-protein duplications and characterization of breakpoints by interphase FISH.

Authors:  K Woodward; E Kendall; D Vetrie; S Malcolm
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

10.  Duplication of the proteolipid protein gene is the major cause of Pelizaeus-Merzbacher disease.

Authors:  E A Sistermans; R F de Coo; I J De Wijs; B A Van Oost
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  37 in total

1.  Breaking away from home.

Authors:  L D Hudson
Journal:  Am J Hum Genet       Date:  2000-05-25       Impact factor: 11.025

Review 2.  Paternal factors and schizophrenia risk: de novo mutations and imprinting.

Authors:  D Malaspina
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

3.  PLP1 and GPM6B intragenic copy number analysis by MAPH in 262 patients with hypomyelinating leukodystrophies: Identification of one partial triplication and two partial deletions of PLP1.

Authors:  Patricia Combes; Marie-Noelle Bonnet-Dupeyron; Fernande Gauthier-Barichard; Raphael Schiffmann; Enrico Bertini; Diana Rodriguez; John A L Armour; Odile Boespflug-Tanguy; Catherine Vaurs-Barrière
Journal:  Neurogenetics       Date:  2006-01-17       Impact factor: 2.660

4.  Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.

Authors:  Anders A F Sima; Christopher R Pierson; Randall L Woltjer; Grace M Hobson; Jeffrey A Golden; William J Kupsky; Galen M Schauer; Thomas D Bird; Robert P Skoff; James Y Garbern
Journal:  Acta Neuropathol       Date:  2009-06-27       Impact factor: 17.088

5.  Modeling the natural history of Pelizaeus-Merzbacher disease.

Authors:  Joshua A Mayer; Ian R Griffiths; James E Goldman; Chelsey M Smith; Elizabeth Cooksey; Abigail B Radcliff; Ian D Duncan
Journal:  Neurobiol Dis       Date:  2015-01-03       Impact factor: 5.996

6.  MicroRNA expression in mouse oligodendrocytes and regulation of proteolipid protein gene expression.

Authors:  Erming Wang; Franca Cambi
Journal:  J Neurosci Res       Date:  2012-04-14       Impact factor: 4.164

7.  Carrier testing for severe childhood recessive diseases by next-generation sequencing.

Authors:  Callum J Bell; Darrell L Dinwiddie; Neil A Miller; Shannon L Hateley; Elena E Ganusova; Joann Mudge; Ray J Langley; Lu Zhang; Clarence C Lee; Faye D Schilkey; Vrunda Sheth; Jimmy E Woodward; Heather E Peckham; Gary P Schroth; Ryan W Kim; Stephen F Kingsmore
Journal:  Sci Transl Med       Date:  2011-01-12       Impact factor: 17.956

8.  Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome.

Authors:  Pawandeep Dhami; Alison J Coffey; Stephen Abbs; Joris R Vermeesch; Jan P Dumanski; Karen J Woodward; Robert M Andrews; Cordelia Langford; David Vetrie
Journal:  Am J Hum Genet       Date:  2005-03-08       Impact factor: 11.025

9.  Nonrecurrent MECP2 duplications mediated by genomic architecture-driven DNA breaks and break-induced replication repair.

Authors:  Marijke Bauters; Hilde Van Esch; Michael J Friez; Odile Boespflug-Tanguy; Martin Zenker; Angela M Vianna-Morgante; Carla Rosenberg; Jaakko Ignatius; Martine Raynaud; Karen Hollanders; Karen Govaerts; Kris Vandenreijt; Florence Niel; Pierre Blanc; Roger E Stevenson; Jean-Pierre Fryns; Peter Marynen; Charles E Schwartz; Guy Froyen
Journal:  Genome Res       Date:  2008-04-02       Impact factor: 9.043

Review 10.  Genes involved in leukodystrophies: a glance at glial functions.

Authors:  Odile Boespflug-Tanguy; Pierre Labauge; Anne Fogli; Catherine Vaurs-Barriere
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.